A detailed history of Ing Groep Nv transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ing Groep Nv holds 906,048 shares of MRK stock, worth $88.8 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
906,048
Previous 1,187,557 23.7%
Holding current value
$88.8 Million
Previous $147 Million 30.02%
% of portfolio
0.62%
Previous 0.89%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$111.15 - $128.97 $31.3 Million - $36.3 Million
-281,509 Reduced 23.7%
906,048 $103 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $46 Million - $49.4 Million
371,769 Added 45.57%
1,187,557 $147 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $54.8 Million - $63.9 Million
-484,136 Reduced 37.24%
815,788 $108 Million
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $74.1 Million - $80.7 Million
740,151 Added 132.22%
1,299,924 $142 Million
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $23.4 Million - $26 Million
-227,004 Reduced 28.85%
559,773 $57.6 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $7.95 Million - $8.67 Million
-73,205 Reduced 8.51%
786,777 $90.8 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $569,052 - $634,946
-5,528 Reduced 0.64%
859,982 $91.5 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $46.6 Million - $59.7 Million
532,541 Added 159.94%
865,510 $96 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $12.5 Million - $14 Million
-147,800 Reduced 30.74%
332,969 $28.7 Million
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $16.1 Million - $18.3 Million
-193,263 Reduced 28.67%
480,769 $43.8 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $18.7 Million - $21 Million
254,827 Added 60.79%
674,032 $55.3 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $1.63 Million - $2.04 Million
-22,571 Reduced 5.11%
419,205 $32.1 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $15.1 Million - $16.6 Million
210,336 Added 90.88%
441,776 $33.2 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $2.68 Million - $2.97 Million
38,144 Added 19.73%
231,440 $18 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $25,409 - $29,929
369 Added 0.19%
193,296 $14.9 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $7.39 Million - $8.2 Million
102,938 Added 114.39%
192,927 $15.8 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $2.74 Million - $3.11 Million
37,454 Added 71.29%
89,989 $7.47 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $3.56 Million - $4.05 Million
-50,525 Reduced 49.02%
52,535 $4.06 Million
Q1 2020

May 06, 2020

SELL
$63.36 - $87.82 $8.71 Million - $12.1 Million
-137,454 Reduced 57.15%
103,060 $7.93 Million
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $3.38 Million - $3.81 Million
-43,532 Reduced 15.33%
240,514 $21.9 Million
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $27 Million - $29.4 Million
-354,548 Reduced 55.52%
284,046 $23.9 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $36.7 Million - $42.8 Million
525,114 Added 462.74%
638,594 $53.5 Million
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $7.15 Million - $8.16 Million
-102,760 Reduced 47.52%
113,480 $9.44 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $16.1 Million - $18.6 Million
-246,016 Reduced 53.22%
216,240 $16.5 Million
Q3 2018

Nov 06, 2018

SELL
$57.69 - $67.84 $6.95 Million - $8.17 Million
-120,412 Reduced 20.67%
462,256 $32.8 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $1.98 Million - $2.32 Million
-38,898 Reduced 6.26%
582,668 $35.4 Million
Q1 2018

May 07, 2018

BUY
$50.96 - $59.23 $695,298 - $808,134
13,644 Added 2.24%
621,566 $33.9 Million
Q4 2017

Feb 06, 2018

SELL
$51.62 - $61.64 $1.04 Million - $1.24 Million
-20,084 Reduced 3.2%
607,922 $34.2 Million
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $36.8 Million - $39.6 Million
628,006
628,006 $40.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.